Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Phase 2 Randomized Study to Compare Ultrasonic Drug Delivery to Standard of Care for the Treatment of Infections in Non-Healing Wounds
Phase 2
- Conditions
- Non-healing WoundAcute Bacterial Skin and Skin Structure Infection (ABSSSI)
- Interventions
- Combination Product: Ultrasonic Drug DeliveryDrug: Standard of Care Antibiotic Treatment
- First Posted Date
- 2018-11-06
- Last Posted Date
- 2018-11-06
- Lead Sponsor
- Sonescence, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT03732365
Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion
- Conditions
- Infection, Soft TissueInfection, WoundCellulitisDiabetic Foot Ulcer
- First Posted Date
- 2010-11-10
- Last Posted Date
- 2018-10-23
- Lead Sponsor
- Sonescence, Inc.
- Registration Number
- NCT01238276
- Locations
- 🇺🇸
Sonoma West Medical Center, Sebastopol, California, United States
News
No news found